About CHEMELEON INC.
Chemeleon provides rapid, instrument-free diagnostics using a proprietary platform technology that delivers colorimetric results in minutes, enabling decentralized testing for a range of analytes including drugs, proteins, and viruses. Their first application is a colorimetric acute myocardial infarction (AMI) diagnostic that offers a visible yes/no readout in under 2 minutes.
Rapid, instrument-free diagnosticsColorimetric readout visible to the naked eyeSample-to-answer format for a broad range of analytes (drugs, proteins, viruses)AMI detection in under 2 minutesMinimal training required for use
Is this your company?
Claim this profile to keep it accurate — and see the federal & state opportunities GovIntel's AI has matched to CHEMELEON INC. right now.
Claim this profile See matched opportunitiesData compiled from public government sources including SAM.gov, USAspending.gov, and state procurement records. Last verified against federal award records. Inaccurate? Let us know.